Adam R. Kalbermatten's Insider Trades & SAST Disclosures

Adam R. Kalbermatten's most recent trade in KORU Medical Systems Inc was a trade of 286,697 Performance Stock Unit done . Disclosure was reported to the exchange on July 1, 2026.

Share

Note

This is a custom search result for pattern Adam R. Kalbermatten.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.

All Superstars

"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches "Balanced Fund" but not "Balanced Growth Fund" Balanced Fund: Use this format without quotation marks to search for all funds related to the term "Balanced Fund" The results may include "Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".

Stock	Client Name	Client Category	Action	Reported to Exchange	Quantity	Post Transaction Holding	Traded %	Avg. Price	Value	Security Type
KORU Medical Systems Inc	Adam R. Kalbermatten	President and CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Jul 2026	286,697	286,697	-		-	Performance Stock Unit
KORU Medical Systems Inc	Adam R. Kalbermatten	President-Chief Commercial Off	Purchase of securities on an exchange or from another person at price $ 3.93 per share.	11 Jun 2026	7,500	312,500 (0%)	0%	3.9	29,475	Common Stick
KORU Medical Systems Inc	Adam R. Kalbermatten	President-Chief Commercial Off	Purchase of securities on an exchange or from another person at price $ 3.96 per share.	11 Jun 2026	5,000	305,000 (0%)	0%	4.0	19,800	Common Stock
KORU Medical Systems Inc	Adam R. Kalbermatten	President-Chief Commercial Off	Grant, award, or other acquisition of securities at price $ 0.00 per share.	17 Mar 2026	67,779	67,779	-		-	Option to buy Common Stock
KORU Medical Systems Inc	Adam R. Kalbermatten	President-Chief Commercial Off	Grant, award, or other acquisition of securities at price $ 0.00 per share.	17 Mar 2026	45,098	45,098	-		-	Restricted Stock Unit
KORU Medical Systems Inc	Adam R. Kalbermatten	President-Chief Commercial Off	Grant, award, or other acquisition of securities at price $ 0.00 per share.	17 Mar 2026	45,098	45,098	-		-	Performance Stock Unit
KORU Medical Systems Inc	Adam R. Kalbermatten	Chief Commercial Officer		28 Jul 2025	600,000	600,000	-		-	Option to buy Common Stock
KORU Medical Systems Inc	Adam R. Kalbermatten	Chief Commercial Officer		28 Jul 2025	300,000	300,000 (0%)	0%		0	Common Stock

*All Values are in $ Million

Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures

Data as reported to USA Exchanges

View All The Insider Trades